Oncoscience #published this #editorial on May 20, 2024 in Volume 11, entitled, “Primary hepatic angiosarcoma: Treatment options for a rare tumor” by Gregory L. Guzik and Ankit Mangla from the Department of Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH; Department of Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH; Department of Hematology and Oncology, Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Cleveland, OH. @UniversityHospitals
#cancer #angiosarcoma #liver #immunotherapy #oncology #research #openaccess #openscience #peerreview #journal #meded #publishing #publication #spotlight
DOI – https://doi.org/10.18632/oncoscience.602
Corresponding author – Ankit Mangla – [email protected]
Sign up for free Altmetric alerts about this article –
https://oncoscience.altmetric.com/details/email_updates?id=10.18632%2Foncoscience.602
Subscribe for free publication alerts from Oncoscience – https://www.oncoscience.us/subscribe/
Keywords – cancer, angiosarcoma, liver angiosarcoma, immunotherapy
About Oncoscience
Oncoscience is a traditional, peer-reviewed, bio-medical oncology research journal with FREE publication for authors and open-access for readers.
To learn more about Oncoscience, please visit https://www.oncoscience.us/ and connect with us:
Facebook – https://www.facebook.com/Oncoscience
X – https://twitter.com/OncoscienceJrnl
Instagram – https://www.instagram.com/oncosciencejrnl/
YouTube – https://www.youtube.com/@OncoscienceJournal
LinkedIn – https://www.linkedin.com/company/oncoscience/
Media Contact
[email protected]
18009220957